IdentificationGeneric Name({[(3E)-2'-Oxo-2',7'-dihydro-2,3'-biindol-3(7H)-ylidene]amino}oxy)acetic acidDrugBank Accession NumberDB07949BackgroundNot AvailableTypeSmall MoleculeGroupsExperimentalStructure


3DDownload MOLSDF3D-SDFPDBSMILESInChI


 Similar StructuresStructure for ({[(3E)-2'-Oxo-2',7'-dihydro-2,3'-biindol-3(7H)-ylidene]amino}oxy)acetic acid (DB07949)× CloseWeightAverage: 335.3135 Monoisotopic: 335.090605919 Chemical FormulaC18H13N3O4SynonymsNot AvailablePharmacologyIndicationNot AvailableReduce drug development failure ratesBuild, train, & validate machine-learning modelswith evidence-based and structured datasets.See how  Build, train, & validate predictive machine-learning models with structured datasets.See howContraindications & Blackbox WarningsAvoid life-threatening adverse drug eventsImprove clinical decision support with information on contraindications & blackbox warnings, population restrictions, harmful risks, & more.Learn more  Avoid life-threatening adverse drug events & improve clinical decision support.Learn morePharmacodynamicsNot AvailableMechanism of actionTargetActionsOrganismUGlycogen phosphorylase, muscle formNot AvailableHumansAbsorptionNot AvailableVolume of distributionNot AvailableProtein bindingNot AvailableMetabolismNot AvailableRoute of eliminationNot AvailableHalf-lifeNot AvailableClearanceNot AvailableAdverse EffectsImprove decision support & research outcomesWith structured adverse effects data, including: blackbox warnings, adverse reactions, warning & precautions, & incidence rates.Learn more  Improve decision support & research outcomes with our structured adverse effects data.Learn moreToxicityNot AvailablePathwaysNot AvailablePharmacogenomic Effects/ADRs 


Not AvailableInteractionsDrug Interactions 


This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist. Not AvailableFood InteractionsNot AvailableCategoriesDrug CategoriesNot AvailableChemical TaxonomyProvided by ClassyfireDescriptionThis compound belongs to the class of organic compounds known as indoles and derivatives. These are organic compounds containing an indole, which is a bicyclic ring system made up of a six-membered benzene ring fused to a five-membered nitrogen-containing pyrrole ring.KingdomOrganic compoundsSuper ClassOrganoheterocyclic compoundsClassIndoles and derivativesSub ClassNot AvailableDirect ParentIndoles and derivativesAlternative ParentsPyrrolines / Oxime ethers / N-acylimines / Ketimines / Propargyl-type 1,3-dipolar organic compounds / Monocarboxylic acids and derivatives / Carboxylic acids / Azacyclic compounds / Organopnictogen compounds / Organic oxides / Hydrocarbon derivatives / Carbonyl compounds


 show 2 moreSubstituentsAliphatic heteropolycyclic compound / Azacycle / Carbonyl group / Carboxylic acid / Carboxylic acid derivative / Hydrocarbon derivative / Imine / Indole or derivatives / Ketimine / Monocarboxylic acid or derivatives / N-acylimine / Organic 1,3-dipolar compound / Organic nitrogen compound / Organic oxide / Organic oxygen compound / Organonitrogen compound / Organooxygen compound / Organopnictogen compound / Oxime ether / Propargyl-type 1,3-dipolar organic compound / Pyrroline


 show 11 moreMolecular FrameworkAliphatic heteropolycyclic compoundsExternal DescriptorsNot AvailableAffected organismsNot AvailableChemical IdentifiersUNIINot AvailableCAS numberNot AvailableInChI KeyBFQRPTKOSYMPOL-LALPNIDTSA-NInChIInChI=1S/C18H13N3O4/c22-14(23)9-25-21-16-11-6-2-4-8-13(11)19-17(16)15-10-5-1-3-7-12(10)20-18(15)24/h1-6H,7-9H2,(H,22,23)/b17-15-,21-16+IUPAC Name2-({[(Z,3E)-2'-oxo-3,7-dihydro-2'H,7'H-[2,3'-biindolyliden]-3-ylidene]amino}oxy)acetic acidSMILESOC(=O)CO\N=C1/C2=CC=CCC2=N/C/1=C1\C(=O)N=C2CC=CC=C12ReferencesGeneral ReferencesNot AvailableExternal LinksPubChem Compound11840955PubChem Substance99444420ChemSpider10015460ZINCZINC000095920659PDBe LigandIAAPDB Entries1z62Clinical TrialsClinical Trials 


PhaseStatusPurposeConditionsCountPharmacoeconomicsManufacturersNot AvailablePackagersNot AvailableDosage FormsNot AvailablePricesNot AvailablePatentsNot AvailablePropertiesStateSolidExperimental PropertiesNot AvailablePredicted PropertiesPropertyValueSourceWater Solubility0.0442 mg/mLALOGPSlogP2.6ALOGPSlogP0.96ChemaxonlogS-3.9ALOGPSpKa (Strongest Acidic)3.47ChemaxonpKa (Strongest Basic)1.97ChemaxonPhysiological Charge-1ChemaxonHydrogen Acceptor Count7ChemaxonHydrogen Donor Count1ChemaxonPolar Surface Area100.68 Å2ChemaxonRotatable Bond Count3ChemaxonRefractivity94.04 m3·mol-1ChemaxonPolarizability34.43 Å3ChemaxonNumber of Rings4ChemaxonBioavailability1ChemaxonRule of FiveYesChemaxonGhose FilterYesChemaxonVeber's RuleNoChemaxonMDDR-like RuleNoChemaxonPredicted ADMET FeaturesPropertyValueProbabilityHuman Intestinal Absorption+0.9818Blood Brain Barrier+0.6119Caco-2 permeable-0.6094P-glycoprotein substrateNon-substrate0.5435P-glycoprotein inhibitor INon-inhibitor0.63P-glycoprotein inhibitor IINon-inhibitor0.6773Renal organic cation transporterNon-inhibitor0.802CYP450 2C9 substrateNon-substrate0.8209CYP450 2D6 substrateNon-substrate0.829CYP450 3A4 substrateSubstrate0.6465CYP450 1A2 substrateNon-inhibitor0.507CYP450 2C9 inhibitorNon-inhibitor0.581CYP450 2D6 inhibitorNon-inhibitor0.8847CYP450 2C19 inhibitorNon-inhibitor0.5469CYP450 3A4 inhibitorNon-inhibitor0.764CYP450 inhibitory promiscuityHigh CYP Inhibitory Promiscuity0.5085Ames testNon AMES toxic0.5343CarcinogenicityNon-carcinogens0.8338BiodegradationNot ready biodegradable0.9825Rat acute toxicity2.4272 LD50, mol/kg Not applicablehERG inhibition (predictor I)Weak inhibitor0.995hERG inhibition (predictor II)Non-inhibitor0.9032  ADMET data is predicted using admetSAR, a free tool for evaluating chemical ADMET properties. (23092397) SpectraMass Spec (NIST)Not AvailableSpectraSpectrumSpectrum TypeSplash KeyPredicted GC-MS Spectrum - GC-MSPredicted GC-MSNot AvailablePredicted MS/MS Spectrum - 10V, Positive (Annotated)Predicted LC-MS/MSNot AvailablePredicted MS/MS Spectrum - 20V, Positive (Annotated)Predicted LC-MS/MSNot AvailablePredicted MS/MS Spectrum - 40V, Positive (Annotated)Predicted LC-MS/MSNot AvailablePredicted MS/MS Spectrum - 10V, Negative (Annotated)Predicted LC-MS/MSNot AvailablePredicted MS/MS Spectrum - 20V, Negative (Annotated)Predicted LC-MS/MSNot AvailablePredicted MS/MS Spectrum - 40V, Negative (Annotated)Predicted LC-MS/MSNot AvailableTargetsBuild, predict & validate machine-learning modelsUse our structured and evidence-based datasets to unlock newinsights and accelerate drug research.Learn more  Use our structured and evidence-based datasets to unlock new insights and accelerate drug research.Learn more


 Details1. Glycogen phosphorylase, muscle formKindProteinOrganismHumansPharmacological actionUnknownGeneral FunctionPyridoxal phosphate bindingSpecific FunctionPhosphorylase is an important allosteric enzyme in carbohydrate metabolism. Enzymes from different sources differ in their regulatory mechanisms and in their natural substrates. However, all known ...Gene NamePYGMUniprot IDP11217Uniprot NameGlycogen phosphorylase, muscle formMolecular Weight97091.265 DaReferencesBerman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. [Article] ×Identify potential medication risksEasily compare up to 40 drugs with our drug interaction checker.Get severity rating, description, and management advice. Learn more   Drug created at September 15, 2010 21:27 / Updated at June 24, 2020 01:34 